Free Trial

Evelo Biosciences (EVLO) SEC Filings & 10K Form

Recent Evelo Biosciences SEC Filings

DateFilerForm TypeView
03/10/2024
11:15 PM
Evelo Biosciences (Filer)
Form EFFECT
01/26/2024
4:26 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
4:27 PM
Evelo Biosciences (Filer)
Form POS AM
01/26/2024
4:28 PM
Evelo Biosciences (Filer)
Form S-8 POS
01/26/2024
4:29 PM
Evelo Biosciences (Filer)
Form S-8 POS
01/26/2024
4:30 PM
Evelo Biosciences (Filer)
Form 15-12G
12/27/2023
8:02 AM
Evelo Biosciences (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
12/12/2023
6:42 AM
Evelo Biosciences (Filer)
Form DEF 14A
12/12/2023
6:43 AM
Evelo Biosciences (Filer)
Form DEFA14A
12/11/2023
8:09 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/04/2023
5:04 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
6:11 AM
Evelo Biosciences (Filer)
Form PRE 14A
11/21/2023
5:44 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:02 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2023
7:31 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:31 PM
Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:32 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
7:32 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
4:24 PM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2023
6:05 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
7:54 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
7:55 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
7:55 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
4:25 PM
Evelo Biosciences (Filer)
Form 424B3
08/21/2023
6:43 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
11:15 PM
Evelo Biosciences (Filer)
Form EFFECT
08/14/2023
7:14 AM
Evelo Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:42 AM
Evelo Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:19 AM
Evelo Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G
08/09/2023
7:44 PM
Bodmer Mark (Reporting)
Evelo Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:42 PM
Evelo Biosciences (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:42 PM
Evelo Biosciences (Issuer)
McHale Duncan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
7:43 PM
Evelo Biosciences (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EVLO) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners